ArticleThe International journal on drug policy2020
No "back to normal" after COVID-19 for our failed drug policies.
Article in The International journal on drug policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Does a take-home dose program result in better patient adherence to methadone? Evidence from Vietnam.Harm reduction journal · 2025Article
- Lessons for future pandemics: Temporal evolution and rural-urban variations in the impacts of the COVID-19 on opioid use treatment.PloS one · 2024Article
- Crisis politics of dehumanisation during COVID-19: A framework for mapping the social processes through which dehumanisation undermines human dignity.British journal of politics & international relations · 2023Article
- Labeled as "drug-seeking": nurses use harm reduction philosophy to reflect on mending mutual distrust between healthcare workers and people who use drugs.Frontiers in public health · 2023Article
- Impacts of COVID-19 at the intersection of substance use disorder treatment and criminal justice systems: findings from three states.Health & justice · 2022Article
- The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.Harm reduction journal · 2022Article
- COVID-19 economic impact payments and opioid overdose deaths.The International journal on drug policy · 2022Observational
- CommunityStat: A Public Health Intervention to Reduce Opioid Overdose Deaths in Burlington, Vermont, 2017-2020.Contemporary drug problems · 2022Article
- Impact ofFrontiers in psychology · 2022Article
- Police discretion in encounters with people who use drugs: operationalizing the theory of planned behavior.Harm reduction journal · 2021Article
- "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.SSM. Qualitative research in health · 2021Article
- HIV's Trajectory: Biomedical Triumph, Structural Failure.American journal of public health · 2021Article
- Representations of Psychoactive Drugs' Use in Mass Culture and Their Impact on Audiences.International journal of environmental research and public health · 2021Review
- An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2021Article
- Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19.Journal of substance abuse treatment · 2021Article
- Beyond Decriminalization: Ending the War on Drugs Requires Recasting Police Discretion through the Lens of a Public Health Ethic.The American journal of bioethics : AJOB · 2021Article
- From public safety to public health: Re-envisioning the goals and methods of policing.Journal of community safety & well-being · 2021Article
- Addressing Racism in Medicine Requires Tackling the Broader Problem of Epistemic Injustice.The American journal of bioethics : AJOB · 2021Article
- Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder.Frontiers in psychiatry · 2021Article
- Barriers and Motivators to Opioid Treatment Among Suburban Women Who Are Pregnant and Mothers in Caregiver Roles.Frontiers in psychology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Before COVID-19 pandemic, advocates had long urged drug policy reforms based on health, security, civil rights, racial justice, fiscal stewardship, and other considerations. In the United States, such calls went largely unanswered. In response to COVID-19, public health and occupational safety concerns have rapidly transformed some drug policies, along with their enforcement. Almost contemporaneously, nationwide protests against violence and racism by militarized police have highlighted the enduring legacy of the Drug War in fueling carceral systems. Disruption from these historical events provides a once-in-a-century opportunity to reconsider the legal architecture of drug policy and policing-both in the U.S. and elsewhere. Rather than returning to a fundamentally broken and inequitable status quo, we urge envisioning a new drug policy in service to life, liberty, and the pursuit of happiness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.